Synergy Pharmaceuticals Inc $4.34

down -0.06


17/4/2014 08:10 PM  |  NASDAQ : SGYP  
Industries : Drugs / Drug Manufacturers - Other
Get Trend Analysis Icon Get SGYP Trend Analysis - it has underperformed the S&P 500 by 37%

Partner Headlines

  1. US Stock Futures Edge Higher Ahead Of Durable-Goods Orders Data

    Benzinga
  2. Synergy Pharmaceuticals Closes Enrollment for Phase 2b Plecanatide Trial ...

    Benzinga
  3. UPDATE: Aegis Capital Reiterates on Synergy Pharmaceuticals on Approaching ...

    Benzinga
  4. Synergy Pharmaceuticals Initiates Phase 3 Clinical Trial of Plecanatide ...

    Benzinga
  5. US Stock Futures Down Ahead Of Jobless Claims Data

    Benzinga
  6. Synergy Initiates Phase 2 Study of SP-333

    Benzinga
  7. US Stock Futures Down; ADP Report In Focus

    Benzinga
  8. Synergy Pharmaceuticals to Initiate Phase 2 Study of SP-333 for Opioid-Induced ...

    Benzinga
  9. Synergy Pharmaceuticals to Spin-Off FV-100 Assets

    Benzinga
  10. Synergy Pharmaceuticals, Inc. (SGYP) Chairman Gabriel Cerrone buys 5,0 ...

    GuruFocus
  11. Synergy Pharmaceuticals, Inc. (SGYP) Chairman Gabriel Cerrone buys 13, ...

    GuruFocus
  12. A Peek Into The Market Before The Trading Starts

    Benzinga
  13. Synergy Pharmaceuticals Initiates Phase I Clinical trial of SP-333 for ...

    Benzinga
  14. Synergy Pharmaceuticals Shareholders Approve Merger with Callisto Pharmaceuticals

    Benzinga
  15. Stocks Soar on Fiscal Cliff Deal; Dow Climbs More Than 300 Points

    Benzinga
  16. UPDATE: Canaccord Genuity Raises PT to $10 on Synergy Pharmaceuticals on ...

    Benzinga
  17. Benzinga's Top Pre-Market Gainers

    Benzinga
  18. Synergy Reports Positive Phase IIb/III Trial Results for Plecanatide in ...

    Benzinga
  19. Aegis Capital Reiterates Buy Rating, $25 PT on Synergy Pharmaceuticals

    Benzinga
  20. A Peek Into The Market Before The Trading Starts

    Benzinga
  21. Synergy Pharmaceuticals Completes Phase I Trial of SP-333 to Treat Gastrointestinal ...

    Benzinga
  22. A Peek Into The Market Before The Trading Starts

    Benzinga
  23. Synergy Begins Phase IIb Trial of Plecanatide for IBS-C

    Benzinga
  24. UPDATE: Canaccord Genuity Initiates Synergy Pharmaceuticals at Buy on Opportunities

    Benzinga
  25. Synergy Pharma Files IND for Gastro Diseases Drug

    Benzinga
  26. LyondellBasell Industries, BP Prudhoe Bay Royalty Included in Stocks Up ...

    FoxBusiness
  27. Synergy Pharma Buys FV-100 Drug from Bristol-Myers

    Benzinga
  28. Low-Priced Small-Caps That Won't Stay That Way

    Benzinga
  29. Synergy Pharmaceuticals Announces Exercise of Remainder of Over-Allotment ...

    Benzinga
  30. Synergy Pharmaceuticals Announces Partial Exercise of Over-Allotment Option ...

    Benzinga
  31. European Patent Office Upholds Synergy Pharmaceuticals' Grant of Claims ...

    Benzinga
Trading Center